MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-WB-10-0023167
Susruta Pharmaceuticals Private Limited
Susruta Pharmaceuticals Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹63.09 Lakh
▼ 26% YoY
Net loss · FY 2022
₹11.15 Lakh
Net margin -17.7%
EBITDA · FY 2022
-₹4.09 Lakh
EBITDA margin -6.5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹70 Lakh
Secured borrowings
Company age
13 yrs
Est. 2013
Directors on board
3
As per MCA filings
About Susruta Pharmaceuticals Private Limited
Data last updated:
Susruta Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 November 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U74900WB2013PTC198456. Its GSTIN is 19AATCS8590D1ZL (West Bengal).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Subhashree Das and Bhaskar Das.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 12 Motilal Nehru Road, Kolkata, West Bengal, India – 700029.
As per the financials filed for FY 2022, the company reported a revenue of ₹63.09 Lakh, a decline of 26% compared to the previous year. For the same year it recorded a net loss of ₹11.15 Lakh (net margin -17.7%) and EBITDA of -₹4.09 Lakh (EBITDA margin -6.5%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years and 14% over five years.
As per MCA filings, the company has open charges of ₹70 Lakh on record. Court records list 3 cases involving the company, including 3 filed by the company; 1 case is pending.
Susruta Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0023167). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74900WB2013PTC198456
Registration Number 198456
Incorporation Date 19 November 2013
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-10-0023167
Recognitions & Rankings of Susruta Pharmaceuticals
Contact details
Susruta Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address12 Motilal Nehru Road, Kolkata, West Bengal, India – 700029
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Susruta Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Susruta Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Susruta Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Susruta Pharmaceuticals Private Limited, buy the company report.
Financials of Susruta Pharmaceuticals Private Limited
FY 2022 filings availableSusruta Pharmaceuticals Private Limited reported revenue of ₹63.09 Lakh (down 26% YoY) for FY 2022.
Revenue · FY 2022
₹63.09 Lakh ▼ 26%
Net loss · FY 2022
₹11.15 Lakh margin -17.7%
EBITDA · FY 2022
-₹4.09 Lakh margin -6.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 26%
3 years · compounded
▼ 30%
5 years · compounded
▼ 14%
EBITDA CAGR growth
1 year
▲ 29%
3 years · compounded
▼ 32%
5 years · compounded
▼ 19%
Revenue has declined at a compounded annual rate (CAGR) of 14% over five years, including a 26% fall in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹63.09 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.09 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹11.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.5% | ||||
| Net Profit Margin | -17.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Susruta Pharmaceuticals Private Limited, buy the company report.
Board of directors of Susruta Pharmaceuticals Private Limited
Susruta Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subhashree Das | Director | 19 Nov 2013 | 12 Years 11 Months | Current |
| Bhaskar Das | Director | 20 Mar 2014 | 12 Years 7 Months | Current |
| Subir Chatterjee | Director | 10 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Susruta Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Genderma Pharmaceuticals Private Limited | ₹63.13 Lakh (FY 2025) | -26.0% | Uttar Pradesh, India | |||
| Susruta Pharmaceuticals Private Limitedthis company | ₹63.09 Lakh (FY 2022) | -₹11.15 Lakh | -17.7% | -26.0% | Kolkata, West Bengal, India | |
| Acer Pharmaceuticals Private Limited | ₹62.91 Lakh (FY 2025) | 32.0% | Chennai, Tamil Nadu, India | |||
| H Zone Remedies Private Limited | ₹62.91 Lakh (FY 2015) | 28.0% | New Delhi, Delhi, India |
To see the full peer comparison of Susruta Pharmaceuticals Private Limited, buy the company report.
Auditor
Susruta Pharmaceuticals Private Limited is audited by SANGRAM DAS & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANGRAM DAS & ASSOCIATES | FY 2022 | 0330671E |
Shareholding
The shareholding of Susruta Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Susruta Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹70 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 May 2016 | 100040003 | Others | ₹45 Lakh | Open | |
| 02 Apr 2015 | 10579843 | Oriental Bank of Commerce | ₹25 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
Susruta Pharmaceuticals Private Limited has 3 court cases on record: 3 filed by Susruta Pharmaceuticals. 1 case is pending and 2 are disposed.
Total cases
3
Filed by the company
3
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Calcutta High Court | Court case (CRR) | Filed by the company against State of West Bengal and Anr and 1 other | Pending |
| High Court, West Bengal | Writ petition | Filed by the company against State of West Bengal and Ors. | Disposed |
| High Court, West Bengal | Writ petition | Filed by the company against The State of West Bengal and Ors. | Disposed |
To see the full case history of Susruta Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Susruta Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Susruta Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AATCS8590D1ZL | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Susruta Pharmaceuticals Private Limited, buy the company report.
Recent activity
Susruta Pharmaceuticals Private Limited has 9 board changes on record since 2013: 3 appointments and 6 cessations. The latest: Subir Chatterjee was appointed as Director on 10 Mar 2023.
Appointed
Subir Chatterjee was appointed as Director.
AGM
Susruta Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Susruta Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Kolkata.
Charges
A charge with Others amounted to Rs. 45.00 Lakh with Charge ID 100040003 was registered on 10 May 2016.
Charges
A charge with Oriental Bank Of Commerce amounted to Rs. 25.00 Lakh with Charge ID 10579843 was registered on 02 Apr 2015.
Ceased
Sajal Kumar Roychoudhury ceased to be Director.
Ceased
Bhaskar Das ceased to be Additional Director.
Appointed
Bhaskar Das was appointed as Director.
Ceased
Sougat Kumar Bandyopadhyay ceased to be Director.
Ceased
Abhijit Hazra ceased to be Director.
Ceased
Soumya Chatterjee ceased to be Director.
Ceased
Srabanee Chakraborty ceased to be Director.
2 earlier events are in the company report.
Frequently asked questions
Susruta Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 November 2013 (13+ years old) and is registered under CIN U74900WB2013PTC198456.
Susruta Pharmaceuticals has 3 current directors:
- Subhashree Das - Director
- Bhaskar Das - Director
- Subir Chatterjee - Director
The latest financial statements of Susruta Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Susruta Pharmaceuticals is 19AATCS8590D1ZL, registered in West Bengal.
The CIN (Corporate Identification Number) of Susruta Pharmaceuticals is U74900WB2013PTC198456. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Susruta Pharmaceuticals has 3 court cases on record: 3 filed by the company. 1 is pending.
Susruta Pharmaceuticals was incorporated on 19 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Susruta Pharmaceuticals by revenue are Genderma Pharmaceuticals Private Limited, Acer Pharmaceuticals Private Limited, H Zone Remedies Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Subir Chatterjee was appointed as Director on 10 Mar 2023. Sajal Kumar Roychoudhury ceased to be Director on 08 Mar 2015. Bhaskar Das ceased to be Additional Director on 30 Sep 2014. Susruta Pharmaceuticals has 9 board changes on record in total.
Yes, Susruta Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-10-0023167).
The registered office of Susruta Pharmaceuticals is at 12 Motilal Nehru Road, Kolkata, West Bengal, India – 700029.